Friday, 23 Oct 2026
Empowering Chinese Pharma’s Global Expansion
Contact US
Home
About US
Policy Hub
Categories
Drug
Company
Deals
Policy / Regulatory
Medical Device
R&D
Legal / IP
Digital
Privacy Policy
Contact US
My News
Cancer
Clinical trial approval / initiation
Product approvals
Clinical trial results
Finance
ADC / XDC
Finanical Reports
Biotech
Market approval filings
PD-1/L1
Read History
Search
Pages
Home
Blog Index
POLICY HUB
Contact Us
Personalized
Read History
Categories
Company
Drug
Policy / Regulatory
Medical Device
R&D
Digital
Legal / IP
Deals
Have an existing account?
Sign In
Follow US
Company
Drug
Zhaoke Ophthalmology’s NVK002 ANDA Accepted for Review by China’s NMPA
January 3, 2025
Company
Medical Device
Grand Pharmaceutical Initiates Study on GPN00289 for Liver Cancer Treatment
January 3, 2025
Company
Drug
SCG Cell Therapy’s SCG142 Receives NMPA Approval for HPV-Related Solid Tumor Clinical Trial
January 3, 2025
Company
Drug
Huadong Medicine’s HDM1005 Receives NMPA Approval for MAFLD/MASH Clinical Trial
January 3, 2025
Company
Deals
Cygenta Partners with IZVARINO Pharma for Comprehensive CDMO Services
January 3, 2025
Company
Deals
Pfizer Collaborates with Atavistik Bio to Discover Allosteric Therapeutics
January 3, 2025
Company
Drug
NMPA Grants Conditional Approval for China’s First MSCs Therapy for aGVHD
January 3, 2025
Company
Medical Device
Genesis MedTech’s iReach Omnia Receives NMPA Approval for Rectal Cancer Surgery
January 2, 2025
Company
Drug
Eli Lilly & Co. Launches Mounjaro (Tirzepatide) in China for Diabetes and Weight Management
January 2, 2025
Company
Deals
Prime Gene Therapeutics Secures Over RMB300 Million in Series B Financing
January 2, 2025
Company
Deals
Brii Biosciences to Acquire Full Rights to BRII-179 from VBI Vaccines
January 2, 2025
Company
Drug
Shanghai Pharmaceuticals Halts Development of I001-B, I022, and C012 in the US
January 2, 2025
1
2
…
286
287
288
289
290
Welcome to Fineline Cube!
Username or Email Address
Password
Remember me
Lost your password?
